David Renas
Plus aucun poste en cours
Provenance du réseau au premier degré de David Renas
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
10
| Public Company | Pharmaceuticals: Major | 10 |
Sangart, Inc.
 Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA.
8
| Extinct | Pharmaceuticals: Major | 8 |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à David Renas via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | General Counsel | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel | |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
| CERUS CORPORATION | Medical Specialties | Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Graduate Degree | |
Idealab Corp.
 Idealab Corp. Investment ManagersFinance Idealab Corp (Idealab) is a venture capital subsidiary of Idealab Holdings LLC founded in 1996 by Bill Gross and Marcia Goodstein. The firm is headquartered in Pasadena, California. | Investment Managers | Corporate Officer/Principal | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | General Counsel | |
| HUMANIGEN, INC. | Biotechnology | Chairman General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree | |
| University of Pennsylvania | College/University | Masters Business Admin | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Investment Committee Member | |
| FIBROGEN, INC. | Pharmaceuticals: Major | General Counsel | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| Creighton University | College/University | Doctorate Degree | |
| Louisiana State University | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of New Mexico | College/University | Corporate Officer/Principal | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Biotechnology | Corporate Officer/Principal | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
| University of the Witwatersrand | College/University | Doctorate Degree | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Society of Critical Care Medicine
 Society of Critical Care Medicine Miscellaneous Commercial ServicesCommercial Services The Society of Critical Care Medicine is a non-profit medical organization founded in 1970. The non-profit company is based in Des Plaines, IL. The company promotes the practice of critical care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Astra Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
| NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
| Connecticut School of Law University Of | College/University | Graduate Degree | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Founder | |
CDR-Life Inc.
 CDR-Life Inc. BiotechnologyHealth Technology CDR-Life Inc. is a Swiss biotherapeutics company that develops novel immunotherapies to target the power of the immune system specifically to tumor cells. CDR-Life is based in Schlieren, Switzerland, and was founded in 2017 by Leonardo Borras, Christian Leisner, Dominik Escher, Rouven Bingel-Erlenmeyer, and Konstantin von Schulthess. The company's proprietary antibody platform targets intracellular tumor antigens presented on the major histocompatibility complex (MHC) with high affinity and specificity, which allows them to develop a pipeline of first-in-class therapeutics across a broad range of solid tumors. The company is backed by leading cross-Atlantic investors and has an existing collaboration and licensing agreement with Boehringer Ingelheim for a novel antibody fragment therapy to treat macular degeneration. Christian Leisner has been the CEO since 2017. | Biotechnology | Director/Board Member | |
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 31 |
| France | 8 |
| Suisse | 4 |
| Royaume-Uni | 3 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 112 |
| Corporate Officer/Principal | 59 |
| Independent Dir/Board Member | 46 |
| General Counsel | 16 |
| Chief Executive Officer | 15 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Healy | 50 |
| Anne VanLent | 23 |
| Rafaèle Elisabeth Tordjman | 23 |
| Barbara Duncan | 22 |
| Brian O'Callaghan | 20 |
| Howard Levy | 11 |
| Carmen Betancourt | 11 |
| R. Wayne Frost | 10 |
| Jacky Vonderscher | 9 |
| Andrew Gomperts | 9 |
| David McElligott | 9 |
| Clive Bertram | 8 |
| Stephanie Brown | 8 |
| Mary Rose Keller | 8 |
| Luigi Marro | 7 |
- Bourse
- Insiders
- David Renas
- Connexions Sociétés
